| Literature DB >> 29350210 |
Gian Pietro Emerenziani1, Maria Chiara Gallotta2, Silvia Migliaccio2, Emanuela A Greco3,4, Chiara Marocco3, Luca di Lazzaro3, Rachele Fornari3, Andrea Lenzi3, Carlo Baldari2, Laura Guidetti2.
Abstract
Entities:
Year: 2017 PMID: 29350210 PMCID: PMC5733938 DOI: 10.1155/2017/7026597
Source DB: PubMed Journal: Int J Endocrinol ISSN: 1687-8337 Impact factor: 3.257
ANOVA results among obese groups (OB, OS, and T2DM).
| Num DF | Den DF |
|
| |
|---|---|---|---|---|
| Variables at maximal effort | ||||
| Ventilation (L min−1) | 2 | 45 | 1.54 | 0.23 |
| | 2 | 45 | 0.66 | 0.52 |
| | 2 | 45 | 0.85 | 0.43 |
| METpeak | 2 | 45 | 0.65 | 0.53 |
| %HRmax | 2 | 45 | 1.42 | 0.25 |
| Variables at IVT | ||||
| | 2 | 45 | 6.79 | 0.003 |
| %VO2peak (%) | 2 | 45 | 9.34 | <0.001 |
| METIVT | 2 | 45 | 6.81 | 0.003 |
| %HRmax (%) | 2 | 45 | 6.41 | 0.004 |
| %HRRIVT (%) | 2 | 45 | 6.86 | 0.003 |
| ΔHR (bpm) | 2 | 45 | 7.48 | 0.002 |
Note: OB: obese subjects; OS: sarcopenic obese subjects; T2DM: type 2 diabetes mellitus; O2: oxygen uptake; MET: metabolic equivalent; %HRmax: percent of theoretical maximal heart rate; %HRR: percent of heart rate reserve.